Published in Int J Oncol on March 01, 1998
Detection of hypermethylation of the p16(INK4A) gene promoter in chronic hepatitis and cirrhosis associated with hepatitis B or C virus. Gut (2001) 1.30
CDKN1C/p57kip2 is a candidate tumor suppressor gene in human breast cancer. BMC Cancer (2008) 1.17
Molecular mechanism underlying the functional loss of cyclindependent kinase inhibitors p16 and p27 in hepatocellular carcinoma. World J Gastroenterol (2008) 1.06
Down-regulation of methylthioadenosine phosphorylase (MTAP) induces progression of hepatocellular carcinoma via accumulation of 5'-deoxy-5'-methylthioadenosine (MTA). Am J Pathol (2011) 1.04
Genomic imprinting and cancer. Mol Pathol (1998) 0.91
p16 and p27 are functionally correlated during the progress of hepatocarcinogenesis. Med Mol Morphol (2006) 0.91
Association of low p16INK4a and p15INK4b mRNAs expression with their CpG islands methylation with human hepatocellular carcinogenesis. World J Gastroenterol (2004) 0.91
H3K27 trimethylation is an early epigenetic event of p16INK4a silencing for regaining tumorigenesis in fusion reprogrammed hepatoma cells. J Biol Chem (2010) 0.90
The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell (1998) 8.33
Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature (2001) 4.99
Activation of the sphingomyelin signaling pathway in intact EL4 cells and in a cell-free system by IL-1 beta. Science (1993) 2.06
Altered patterns of MDM2 and TP53 expression in human bladder cancer. J Natl Cancer Inst (1994) 1.52
[Updating of prognostic factors in bladder carcinoma]. Med Clin (Barc) (1991) 1.39
Deletions of the INK4A gene occur in malignant peripheral nerve sheath tumors but not in neurofibromas. Am J Pathol (1999) 1.18
A critical role for choline kinase-alpha in the aggressiveness of bladder carcinomas. Oncogene (2009) 1.09
Molecular analyses of the mitotic checkpoint components hsMAD2, hBUB1 and hBUB3 in human cancer. Int J Cancer (2001) 1.06
Prognostic significance of transcription factor E2F-1 in bladder cancer: genotypic and phenotypic characterization. J Natl Cancer Inst (1999) 1.02
Cyclin-dependent kinase inhibitor p57KIP2 in soft tissue sarcomas and Wilms'tumors. Cancer Res (1996) 0.97
Presence of human papilloma virus in tumor tissue from children with retinoblastoma: an alternative mechanism for tumor development. Clin Cancer Res (2000) 0.97
Genetic alterations of the p14ARF -hdm2-p53 regulatory pathway in breast carcinoma. Breast Cancer Res Treat (2001) 0.96
Genetic evidence in melanoma and bladder cancers that p16 and p53 function in separate pathways of tumor suppression. Am J Pathol (1995) 0.95
A rise and fall in 1,2-diacylglycerol content signal hexamethylene bisacetamide-induced erythropoiesis. J Biol Chem (1992) 0.85
Involvement of the Ink4a gene (p16 and p19arf) in murine tumorigenesis. Int J Oncol (1999) 0.85
Analysis of p21WAF1/CIP1 in primary bladder tumors. Oncol Res (1996) 0.82
Microsatellite instability and deletion analysis of chromosome 10 in human prostate cancer. Int J Cancer (1996) 0.81
Genotypic and phenotypic characterization of the histoblood group ABO(H) in primary bladder tumors. Int J Cancer (1998) 0.80
Cigarette smoking and chromosome 9 alterations in bladder cancer. Cancer Epidemiol Biomarkers Prev (1997) 0.80
Molecular analysis of the INK4A and INK4B gene loci in human breast cancer cell lines and primary carcinomas. Cancer Genet Cytogenet (2001) 0.79
Alterations of cell cycle regulators affecting the RB pathway in nonfamilial retinoblastoma. Hum Pathol (2001) 0.78
Estimating the relative risk of developing melanoma in INK4A carriers. Eur J Cancer Prev (2004) 0.77
Mutagen sensitivity as an indicator of soft tissue sarcoma risk. Environ Mol Mutagen (2001) 0.76
Alterations in the retinoblastoma pathway of cell cycle control in parathyroid tumors. Oncol Rep (2000) 0.76
[Morphologic changes and pathologic anatomy associated with acquired immune deficiency syndrome]. Med Clin (Barc) (1986) 0.75
[Immunopathology (II)]. Med Clin (Barc) (1985) 0.75
[The AIDS virus]. Med Clin (Barc) (1986) 0.75
[Cell cycle and cancer]. Rev Clin Esp (1996) 0.75
[Applications to clinico-pathological diagnosis of in situ hybridization]. Med Clin (Barc) (1990) 0.75
Characterization of the tobacco glycoprotein surface binding property of heart and skeletal muscle cells. I. Modulation of the heart cell membrane TGP interaction by anti-TGP IgG. Arch Toxicol (1995) 0.75
[Pure sensory neuropathy. Restriction of the Hu antibody to the sensory neuropathy associated with small cell carcinoma of the lung]. Neurologia (1990) 0.75
[Multiple drug resistance. Biological and clinica implications]. Med Clin (Barc) (1989) 0.75
[The barley cell or mastocyte: cellular and molecular biology]. Med Clin (Barc) (1985) 0.75